Al-Hassan M Mustafa (Oliver H Krämer)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Gene Expression

Histone Deacetylase

Induced Apoptosis

Top Venues

Pharmacological reviews

Archives of toxicology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ramy Ashry, Al-Hassan M Mustafa, Kristin Hausmann, Michael Linnebacher, Susanne Strand, Wolfgang Sippl, Matthias Wirth, Oliver Holger Krämer
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor. Cancers 15 (14) (2023)
Oliver Holger Krämer, Ramy Ashry, Al-Hassan M Mustafa
Monitoring Changes in Intracellular Reactive Oxygen Species Levels in Response to Histone Deacetylase Inhibitors. Methods in molecular biology (Clifton, N.J.) 2589 (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacological reviews 75 (1) (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacological reviews 75 (1) (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacological reviews 75 (1) (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacological reviews 75 (1) (2022)
Al-Hassan M Mustafa, Oliver Holger Krämer
Novel insight into mechanisms for ATR activation by chromatin structures. Archives of toxicology 95 (10) (2021)
Vanessa Wachholz, Al-Hassan M Mustafa, Yanira Zeyn, Sven J Henninger, Mandy Beyer, Melanie Dzulko, Andrea Piée-Staffa, Christina Brachetti, Patricia S Haehnel, Andreas Sellmer, Siavosh Mahboobi, Thomas Kindler, Walburgis Brenner, Teodora Nikolova, Oliver Holger Krämer
Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3. Archives of toxicology (2021)
Hany S Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, Matthes Zessin, Al-Hassan M Mustafa, Marten A Fischer, Patrik Zeyen, Ping Sun, Emre F Bülbül, Anita Vecchio, Frank Erdmann, Matthias Schmidt, Dina Robaa, Cyril Barinka, Christophe Romier, Mike Schutkowski, Oliver Holger Krämer, Wolfgang Sippl
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity. International journal of molecular sciences 23 (1) (2021)